These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9917083)

  • 1. Pharmacodynamic profile of prolonged etoposide administration in patients with small cell lung cancer and non-Hodgkin's lymphoma.
    Higa GM; Sarkar MA; DeVore RF
    Pharmacotherapy; 1999 Jan; 19(1):101-7. PubMed ID: 9917083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer.
    Zucchetti M; Pagani O; Torri V; Sessa C; D'Incalci M; De Fusco M; de Jong J; Gentili D; Martinelli G; Tinazzi A
    Clin Cancer Res; 1995 Dec; 1(12):1517-24. PubMed ID: 9815952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of 21-day oral etoposide in patients with advanced non-small cell lung cancer.
    Miller AA; Tolley EA; Niell HB
    Clin Cancer Res; 1998 Jul; 4(7):1705-10. PubMed ID: 9676845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic monitoring of continuous infusion etoposide in small-cell lung cancer.
    Joel SP; Ellis P; O'Byrne K; Papamichael D; Hall M; Penson R; Nicholls S; O'Donnell C; Constantinou A; Woodhull J; Nicholson M; Smith I; Talbot D; Slevin M
    J Clin Oncol; 1996 Jun; 14(6):1903-12. PubMed ID: 8656259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged administration of low dose infusional etoposide in patients with advanced malignancies. A phase I/II study.
    Thompson DS; Hainsworth JD; Hande KR; Holzmer M; Greco FA
    Cancer; 1994 Jun; 73(11):2824-31. PubMed ID: 8194024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of three daily infusions of etoposide in patients with extensive-stage small-cell lung cancer.
    Miller AA; Tolley EA; Niell HB; Stewart CF; Griffin JP
    Cancer Chemother Pharmacol; 1992; 31(2):161-6. PubMed ID: 1333371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
    Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
    J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic optimisation of treatment with oral etoposide.
    Toffoli G; Corona G; Basso B; Boiocchi M
    Clin Pharmacokinet; 2004; 43(7):441-66. PubMed ID: 15139794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity.
    Clark PI; Slevin ML; Joel SP; Osborne RJ; Talbot DI; Johnson PW; Reznek R; Masud T; Gregory W; Wrigley PF
    J Clin Oncol; 1994 Jul; 12(7):1427-35. PubMed ID: 8021734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
    Miller AA; Rosner GL; Ratain MJ; Hollis DR; Green MR; Schilsky RL
    Clin Cancer Res; 1997 May; 3(5):719-25. PubMed ID: 9815741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study.
    Porter D; Boddy A; Thomas H; Lind M; Newell D; Calvert AH; Robson L; Brampton M; Abrahamsen D; Winograd B
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):34-44. PubMed ID: 8996574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer.
    Miller AA; Tolley EA; Niell HB; Griffin JP; Mauer AM
    J Clin Oncol; 1993 Jun; 11(6):1179-88. PubMed ID: 8388920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of oral etoposide dosage in elderly patients with non-Hodgkin's lymphoma using the fraction of dose absorbed measured for each patient.
    el-Yazigi A; Ezzat A; Berry J; Raines DA; Yusuf A; al-Rawithi S; Legayada ES
    J Clin Pharmacol; 2000 Feb; 40(2):153-60. PubMed ID: 10664921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacodynamics of continuous-infusion etoposide.
    Miller AA; Stewart CF; Tolley EA
    Cancer Chemother Pharmacol; 1990; 25(5):361-6. PubMed ID: 2155063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance.
    Lum BL; Kaubisch S; Fisher GA; Brown BW; Sikic BI
    Cancer Chemother Pharmacol; 2000; 45(4):305-11. PubMed ID: 10755319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacologic study of 7- and 21-day continuous etoposide infusion in patients with advanced cancer.
    Robert F; Chen S; Miller AA; Lee BC; Molthrop DC; Wheeler RH
    Cancer Chemother Pharmacol; 1996; 38(5):459-65. PubMed ID: 8765440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer.
    Dowlati A; Levitan N; Gordon NH; Hoppel CL; Gosky DM; Remick SC; Ingalls ST; Berger SJ; Berger NA
    Cancer Chemother Pharmacol; 2001; 47(2):141-8. PubMed ID: 11269740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics and pharmacodynamics of oral etoposide.
    Toffoli G; Corona G; Sorio R; Robieux I; Basso B; Colussi AM; Boiocchi M
    Br J Clin Pharmacol; 2001 Nov; 52(5):511-9. PubMed ID: 11736859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated doses of oral etoposide in the treatment of patients with aids-related kaposi sarcoma: a clinical and pharmacologic study to improve therapeutic index.
    Sprinz E; Caldas AP; Mans DR; Cancela A; DiLeone L; Dalla Costa T; Schwartsmann G
    Am J Clin Oncol; 2001 Apr; 24(2):177-84. PubMed ID: 11319295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical and pharmacokinetic study of a 14-day infusion of etoposide in patients with lung cancer.
    Minami H; Shimokata K; Saka H; Saito H; Ando Y; Senda K; Nomura F; Sakai S
    J Clin Oncol; 1993 Aug; 11(8):1602-8. PubMed ID: 8336196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.